Abstract
Silver sulfadiazine, an anti-infectious agent for the prevention and treatment of burn sepsis, has been found to possess antitreponemal activity against Treponema pallidum. At 28 C, complete inactivation of the organism was produced by exposure of the organism to a concentration of 50 μg of the drug per ml for 1 to 5 min, 12 to 25 μg/ml for 10 to 15 min, and 6.2 μg/ml for 30 min. At 37 C, the amounts of silver sulfadiazine required for inactivation were two- to fourfold less.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Fox C. L., Jr Silver sulfadiazine--a new topical therapy for Pseudomonas in burns. Therapy of Pseudomonas infection in burns. Arch Surg. 1968 Feb;96(2):184–188. doi: 10.1001/archsurg.1968.01330200022004. [DOI] [PubMed] [Google Scholar]
- Lindberg R. B., Moncrief J. A., Switzer W. E., Order S. E., Mills W., Jr The successful control of burn wound sepsis. J Trauma. 1965 Sep;5(5):601–616. doi: 10.1097/00005373-196509000-00004. [DOI] [PubMed] [Google Scholar]
- Perine P. L., Weiser R. S., Klebanoff S. J. Immunity to syphilis. I. Passive transfer in rabbits with hyperimmune serum. Infect Immun. 1973 Nov;8(5):787–790. doi: 10.1128/iai.8.5.787-790.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wlodkowski T. J., Rosenkranz H. S. Antifungal activity of silver sulphadiazine. Lancet. 1973 Sep 29;2(7831):739–740. doi: 10.1016/s0140-6736(73)92576-2. [DOI] [PubMed] [Google Scholar]